General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statement of Cash Flows

v3.21.2
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Operating Activities:        
Net loss $ (21,109) $ (10,934) $ (17,985) $ (29,875)
Adjustments to reconcile net loss to cash used in operating activities        
Depreciation 841 907 1,795 1,359
Provision for doubtful accounts 378 397 591 1,014
Reserve for excess and obsolete inventory 56 263 37 762
Stock-based compensation expense 2,971 1,007 2,569 858
Loss on sale of assets     0 35
Changes in operating assets and liabilities        
Accounts receivable (1,345) 5,678 967 (3,959)
Inventory (1,430) (3,244) (808) (2,180)
Prepaid expenses (196) (206) (333) 150
Other current assets 559 1,457 840 (1,644)
Other assets (60) (17) 49 183
Accounts payable and accrued expenses 2,350 (1,398) 852 (318)
Other current liabilities (242) (366) 484
Deferred rent 409 (76) 100 198
Other liabilities 1,249 13 175 220
Deferred revenue (1,088) 1,301 5,058 2,046
Net cash used in operating activities (16,384) (5,094) (6,459) (30,667)
Investing Activities:        
Purchases of property and equipment (1,039) (243) (640) (4,770)
Proceeds from sale and disposal of fixed assets     118 138
Net cash used in investing activities (1,039) (243) (522) (4,632)
Financing Activities:        
Proceeds (repayments) of debt obligations (5,022) 5,192    
Payment of transaction costs      
Proceeds from debt obligations     5,022 0
Proceeds from the issuance of Series D convertible preferred stock     0 82,239
Costs from issuance of Series D convertible preferred stock     0 (113)
Proceeds from exercise of Series D warrants 455 350 700 150
Proceeds from the exercise of common stock options 419 485 1,131 390
Repurchase of Seed Series convertible preferred stock     0 (805)
Repurchase of common stock     (826) (624)
Taxes paid related to net share settlement of equity awards     (98) 0
Payment of financing costs     0 (38)
Principal repayments of capital lease obligations   (1) (1) (14)
Net cash (used in) provided by financing activities (8,148) 6,026 5,928 81,185
Net change in cash and cash equivalents (25,571) 689 (1,053) 45,886
Cash and cash equivalents        
Beginning of year 58,715 59,768 59,768 13,882
End of year 33,144 60,457 58,715 59,768
Supplemental disclosure of cash flow information        
Cash paid for interest     0 1
Cash paid for income taxes     84 15
Non-cash financing and investing activities        
Deferred transaction costs included in accounts payable and accrued expenses 885      
De-recognition of warrant liability to additional paid-in capital $ 1,793      
Note receivable for exercise of common stock options . . . .   $ 170 $ 0 $ 170